BioMall
Brand Store/BDB Bioscience/BD PharmingenTM PerCP-CyTM5.5 Mouse Anti-Human IL-17A
BD PharmingenTM PerCP-CyTM5.5 Mouse Anti-Human IL-17A
GENERAL CATALOGUE

BD PharmingenTM PerCP-CyTM5.5 Mouse Anti-Human IL-17A

560799 ·

BDB Bioscience · Cat: 560799

₹350 – ₹550 approx.This price excludes freight and taxes. Please RFQ to get the final price.

Reach 3+ verified distributors

Catalog No: 560799
Category: reagents
Brand: BDB Bioscience

Description

Flow cytometric analysis of IL-17A in stimulated human lymphocytes. Human peripheral blood mononuclear cells PBMC were stimulated with PMA and Ionomycin in the presence of BD GolgiStop Cat. No. 554724 for 5 hours. Cells were then fixed and permeabilized using BD Cytofix/ Cytoperm reagents Cat. No. 554714 followed by staining with PerCP-Cy5.5 anti-human IL-17A, FITC anti-human IFN-gamma Cat. No. 554700 , and APC anti-human IL-4 Cat. No. 554486 . Two-color flow cytometric dot plots showing the correlated expression patterns of IL-17A vs IFN-gamma Left panel or IL-4 Right panel were derived from gated events with the forward and side light-scatter characteristics of viable lymphocytes. Flow cytometry was performed with doublet discrimination using a BD LSRII System. Flow cytometric analysis of IL-17A in stimulated human lymphocytes. Human peripheral blood mononuclear cells PBMC were stimulated with PMA and Ionomycin in the presence of BD GolgiStop Cat. No. 554724 for 5 hours. Cells were then fixed and permeabilized using BD Cytofix/ Cytoperm reagents Cat. No. 554714 followed by staining with PerCP-Cy5.5 anti-human IL-17A, FITC anti-human IFN-gamma Cat. No. 554700 , and APC anti-human IL-4 Cat. No. 554486 . Two-color flow cytometric dot plots showing the correlated expression patterns of IL-17A vs IFN-gamma Left panel or IL-4 Right panel were derived from gated events with the forward and side light-scatter characteristics of viable lymphocytes. Flow cytometry was performed with doublet discrimination using a BD LSRII System. Flow cytometric analysis of IL-17A in stimulated human lymphocytes. Human peripheral blood mononuclear cells PBMC were stimulated with PMA and Ionomycin in the presence of BD GolgiStop Cat. No. 554724 for 5 hours. Cells were then fixed and permeabilized using BD Cytofix/ Cytoperm reagents Cat. No. 554714 followed by staining with PerCP-Cy5.5 anti-human IL-17A, FITC anti-human IFN-gamma Cat. No. 554700 , and APC anti-human IL-4 Cat. No. 554486 . Two-color flow cytometric dot plots showing the correlated expression patterns of IL-17A vs IFN-gamma Left panel or IL-4 Right panel were derived from gated events with the forward and side light-scatter characteristics of viable lymphocytes. Flow cytometry was performed with doublet discrimination using a BD LSRII System. Show More Flow cytometric analysis of IL-17A in stimulated human lymphocytes. Human peripheral blood mononuclear cells PBMC were stimulated with PMA and Ionomycin in the presence of BD GolgiStop Cat. No. 554724 for 5 hours. Cells were then fixed and permeabilized using BD Cytofix/ Cytoperm reagents Cat. No. 554714 followed by staining with PerCP-Cy5.5 anti-human IL-17A, FITC anti-human IFN-gamma Cat. No. 554700 , and APC anti-human IL-4 Cat. No. 554486 . Two-color flow cytometric dot plots showing the correlated expression patterns of IL-17A vs IFN-gamma Left panel or IL-4 Right panel were derived from gated events with the forward and side light-scatter characteristics of viable lymphocytes. Flow cytometry was performed with doublet discrimination using a BD LSRII System. Show More Flow cytometric analysis of IL-17A in stimulated human lymphocytes. Human peripheral blood mononuclear cells PBMC were stimulated with PMA and Ionomycin in the presence of BD GolgiStop Cat. No. 554724 for 5 hours. Cells were then fixed and permeabilized using BD Cytofix/ Cytoperm reagents Cat. No. 554714 followed by staining with PerCP-Cy5.5 anti-human IL-17A, FITC anti-human IFN-gamma Cat. No. 554700 , and APC anti-human IL-4 Cat. No. 554486 . Two-color flow cytometric dot plots showing the correlated expression patterns of IL-17A vs IFN-gamma Left panel or IL-4 Right panel were derived from gated events with the forward and side light-scatter characteristics of viable lymphocytes. Flow cytometry was performed with doublet discrimination using a BD LSRII System. Flow cytometric analysis of IL-17A in stimulated human lymphocytes. Human peripheral blood mononuclear cells PBMC were stimulated with PMA and Ionomycin in the presence of BD GolgiStop Cat. No. 554724 for 5 hours. Cells were then fixed and permeabilized using BD Cytofix/ Cytoperm reagents Cat. No. 554714 followed by staining with PerCP-Cy5.5 anti-human IL-17A, FITC anti-human IFN-gamma Cat. No. 554700 , and APC anti-human IL-4 Cat. No. 554486 . Two-color flow cytometric dot plots showing the correlated expression patterns of IL-17A vs IFN-gamma Left panel or IL-4 Right panel were derived from gated events with the forward and side light-scatter characteristics of viable lymphocytes. Flow cytometry was performed with doublet discrimination using a BD LSRII System.

More from BDB Bioscience

BD HorizonTM BV421 Mouse Anti-Human TIGIT
BD HorizonTM BV421 Mouse Anti-Human TIGIT
570445
reagents
BD OptiBuildTM BV750 Mouse Anti-Human HLA-DQ
BD OptiBuildTM BV750 Mouse Anti-Human HLA-DQ
746968
reagents
BD OptiBuildTM BV750 Rat Anti-Mouse CD93 (Early B Lineage)
BD OptiBuildTM BV750 Rat Anti-Mouse CD93 (Early B Lineage)
746849
reagents
BD OptiBuildTM BV510 Rat Anti-Mouse Delta-Like Protein 1
BD OptiBuildTM BV510 Rat Anti-Mouse Delta-Like Protein 1
744997
reagents
BD OptiBuildTM BUV805 Mouse Anti-Human CD275
BD OptiBuildTM BUV805 Mouse Anti-Human CD275
748933
reagents
BD OptiBuildTM BV650 Rat Anti-Mouse CD23
BD OptiBuildTM BV650 Rat Anti-Mouse CD23
740456
reagents
BD OptiBuildTM R718 Rat Anti-Mouse CCRL2
BD OptiBuildTM R718 Rat Anti-Mouse CCRL2
752021
reagents
BD PharmingenTM Mouse B Lymphocyte Activation Antibody Cocktail, with Isotype Control; PE-CyTM7 CD25, PE CD69, & FITC CD19
BD PharmingenTM Mouse B Lymphocyte Activation Antibody Cocktail, with Isotype Control; PE-CyTM7 CD25, PE CD69, & FITC CD19
558064
reagents